P
US6645481B1ExpiredUtilityPatentIndex 82

Method of achieving overnight laxation and control of bowel function

Assignee: BRAINTREE LABPriority: Sep 28, 2000Filed: Sep 28, 2000Granted: Nov 11, 2003
Est. expirySep 28, 2020(expired)· nominal 20-yr term from priority
Inventors:CLEVELAND MARK VBPELHAM RUSSELL W
A61P 1/00A61K 31/765A61P 1/06A61P 1/10
82
PatentIndex Score
15
Cited by
10
References
29
Claims

Abstract

Overnight relief of constipation symptoms is achieved, and control of bowel function is enhanced by oral administration of an effective or sufficient amount of a composition comprising polyethylene glycol (PEG), preferably dispersed and or dissolved in an aqueous medium. The PEG compositions used for the present invention are preferably substantially free of ancillary electrolytes.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
       1. A method of achieving overnight relief of constipation symptoms in a patient experiencing constipation, the method comprising the step of administering a laxation-inducing composition consisting essentially of polyethylene glycol, in an amount sufficient to induce a controlled bowel movement within 12 to 24 hours. 
     
     
       2. The method of  claim 1  wherein the composition is substantially free of electrolytes. 
     
     
       3. The method of  claim 1  wherein the polyethylene glycol has an average molecular weight greater than 1000. 
     
     
       4. The method of  claim 1  wherein the polyethylene glycol has an average molecular weight ranging from 3000 to 8000. 
     
     
       5. The method of  claim 4  wherein the polyethylene glycol is PEG 3350. 
     
     
       6. The method of  claim 1  wherein the composition comprises a dosage from about 5 to about 200 g of polyethylene glycol. 
     
     
       7. The method of  claim 6  wherein the composition comprises from about 10 to about 34 g of polyethylene glycol per dose. 
     
     
       8. The method of  claim 7  wherein the composition comprises 17 g of polyethylene glycol per dose. 
     
     
       9. The method of  claim 8  wherein the polyethylene glycol is dispersed in an aqueous medium. 
     
     
       10. The method of  claim 8  wherein the polyethylene glycol is in solid form. 
     
     
       11. The method of  claim 8  wherein the composition is administered up to four times per day. 
     
     
       12. The method of  claim 1  wherein overnight relief of constipation symptoms in a patient experiencing constipation is achieved by alternately administering the laxation inducing composition for a first period of time and discontinuing administration of the compound for a second period of time. 
     
     
       13. The method of  claim 12  wherein the first and the second time periods are of equal duration. 
     
     
       14. The method of  claim 12  wherein the first and the second time periods are unequal in duration. 
     
     
       15. A method of enhancing a patient's control of bowel function, the method comprising the step of administering a laxation-inducing composition consisting essentially of polyethylene glycol, in an amount sufficient to enhance control of bowel function within 12 to 24 hours. 
     
     
       16. The method of  claim 15  wherein the composition is substantially free of electrolytes. 
     
     
       17. The method of  claim 15  wherein the polyethylene glycol has an average molecular weight greater than 1000. 
     
     
       18. The method of  claim 15  wherein the polyethylene glycol has an average molecular weight ranging from 3000 to 8000. 
     
     
       19. The method of  claim 18  wherein the polyethylene glycol is PEG 3350. 
     
     
       20. The method of  claim 15  wherein the composition comprises a dosage from about 5 to about 200 g of polyethylene glycol. 
     
     
       21. The method of  claim 20  wherein the composition comprises from about 10 to about 34 g of polyethylene glycol per dose. 
     
     
       22. The method of  claim 21  wherein the composition comprises 17 g of polyethylene glycol per dose. 
     
     
       23. The method of  claim 22  wherein the polyethylene glycol is dispersed in an aqueous medium. 
     
     
       24. The method of  claim 22  wherein the polyethylene glycol is in solid form. 
     
     
       25. The method of  claim 22  wherein the composition is administered up to four times per day. 
     
     
       26. The method of  claim 12  wherein control is achieved for several days even after the composition is discontinued. 
     
     
       27. The method of  claim 15  wherein the patient's control of bowel function is enhanced by alternately administering the laxation inducing composition for a first period of time and discontinuing administration of the compound for a second period of time. 
     
     
       28. The method of  claim 27  wherein the first and the second time periods are of equal duration. 
     
     
       29. The method of  claim 27  wherein the first and the second time periods are unequal in duration.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.